drugset / Trial / NCT01123395

Bioavailability Study of Colcrys® in Apple Juice

NCT01123395

Phase 1 Completed 16 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate and compare the relative bioavailability of a single 0.6 mg tablet of Colcrys® (colchicine, USP) when crushed and dissolved in apple juice relative to the same dose given as an intact tablet to healthy subjects following an overnight fast.

Timeline

Start
2010-05
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral

Indications

No indication recorded.